GGrantIndex
Sort

23,748 grants matching melanoma

Role of Tumor Stroma in Therapeutic Response and Resistance

$930,118
Lynda Chin · University Of Tx Md Anderson Can Ctr · U54 · FY2011 · CA

Functional genomic analysis of neural crest development

$929,665
William J Pavan · National Human Genome Research Institute · ZIA · FY2018 · HG

Analysis of Dominant Megacolon: Another Hirschsprung Disease Model

$929,665
William J Pavan · National Human Genome Research Institute · ZIA · FY2018 · HG

Vaccines and Therapeutics for Anthrax

$928,890
Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Pathology of SN and non-SN in Patients with Melanoma

$927,670
Alistair John Cochran · Saint John'S Cancer Institute · P01 · FY2011 · CA

Overcoming resistance to anti-PD1 immunotherapy

$927,149
Thomas F Gajewski · University Of Chicago · R35 · FY2023 · CA

Preclinical Development of a Novel and Powerful Immunotherapeutic

$926,922
Susan Dana Jones · Immurx Llc · R44 · FY2011 · AI

Cytokine Gene Therapy of Cancer - Preclinical Studies

$925,900
Walter J Storkus · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA

Evolution of Primary and Resistant Solid Tumors

$925,724
Ronald Anthony Depinho · Dana-Farber Cancer Inst · U01 · FY2007 · CA

Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1

$925,537
Chengkai Dai · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

IMMUNE PROFILING OF SENTINEL LYMPH NODES IN MELANOMA. NEW AWARD.

$924,815
Cedars-Sinai Medical Center · · FY2020 · Defense Health Agency

Cancer Deep Phenotype Extraction from Electronic Medical Records

$924,689
Guergana K. Savova · Boston Children'S Hospital · U24 · FY2020 · CA

Overcoming resistance to anti-PD1 immunotherapy

$924,579
Thomas F Gajewski · University Of Chicago · R35 · FY2022 · CA

Regulation of Lymphocyte Proliferation and Replicative Capacity

$923,719
Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

tRNA modification reprogramming and translational remodeling in cancer

$922,755
Richard I. Gregory · Univ Of Massachusetts Med Sch Worcester · U01 · FY2025 · CA

Immunomodulatory Therapy for Neuropathic Pain

$922,476
Ridong Chen · Apt Therapeutics, Inc. · R44 · FY2022 · NS

Molecular and immunologic evolution of melanomas from pre-neoplastic lesions

$922,472
Boris C Bastian · University Of California, San Francisco · R35 · FY2019 · CA

Characterization of Cancer Stem Cells

$922,149
William Farrar · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

DEVELOPMENT OF A NANOSECOND PULSED ELECTRIC FIELD SYSTEM TO TREAT SKIN CANCER

$921,906
Richard Lee Nuccitelli · Bioelectromed Corporation · R44 · FY2011 · CA

SINGLE-CELL ANALYSIS OF LAG3 CHECKPOINT INHIBITION IN METASTATIC UVEAL MELANOMA

$921,000
University Of Miami · · FY2021 · Department of the Army

Studies of Populations Exposed to Occupational Sources of Radiation

$920,982
Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA

Characterization Unit

$920,319
David Liu · Dana-Farber Cancer Inst · U2C · FY2021 · CA

A single-cell device to capture and analyze rare T-cells from solid tumors.

$920,072
Timothy S McConnell · Isoplexis, Inc. · R44 · FY2018 · CA

Molecular and immunologic evolution of melanomas from pre-neoplastic lesions

$920,052
Boris C Bastian · University Of California, San Francisco · R35 · FY2023 · CA

Regulation of innate lymphocyte function

$919,783
Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI